艾切托(ACET)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACET 艾切托

未开盘 02-24 16:00:00 EST

7.36

+0.43

+6.20%

盘后7.36

+0.000.00%

17:46 EST

最高7.50	最低6.88	成交量12.62万
今开6.88	昨收6.93	日振幅8.95%
总市值7,050万	流通市值6,072万	总股本957.85万
成交额91.34万	换手率1.53%	流通股本825.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACET","market":"US","secType":"STK","nameCN":"艾切托","latestPrice":7.36,"timestamp":1771966800000,"preClose":6.93,"halted":0,"volume":126241,"hourTrading":{"tag":"盘后","latestPrice":7.36,"preClose":7.36,"latestTime":"17:46 EST","volume":46,"amount":338.98,"timestamp":1771973163293,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.06204906204906214,"floatShares":8250000,"shares":9578473,"eps":-20.176992,"marketStatus":"未开盘","change":0.43,"latestTime":"02-24 16:00:00 EST","open":6.88,"high":7.5,"low":6.88,"amount":913382.001353,"amplitude":0.089466,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-20.176992,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772010000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1516942800000,"exchange":"NASDAQ","adjPreClose":6.93,"postHourTrading":{"tag":"盘后","latestPrice":7.36,"preClose":7.36,"latestTime":"17:46 EST","volume":46,"amount":338.98,"timestamp":1771973163293,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.598586,"impliedVol":0.2864,"impliedVolPercentile":0.04},"requestUrl":"/m/hq/s/ACET","defaultTab":"news","newsList":[{"id":"2612849335","title":"艾切托盘中异动 快速下挫5.35%报6.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612849335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612849335?lang=zh_cn&edition=full","pubTime":"2026-02-17 23:06","pubTimestamp":1771340795,"startTime":"0","endTime":"0","summary":"北京时间2026年02月17日23时06分，艾切托股票出现波动，股价大幅下跌5.35%。截至发稿，该股报6.54美元/股，成交量3.556万股，换手率0.37%，振幅5.07%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。艾切托股票所在的生物技术行业中，整体涨幅为0.16%。艾切托公司简介：Adicet Bio Inc是一家临床阶段的生物技术公司，发现和开发用于癌症和其他疾病的异体γ δ T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217230635a70481e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217230635a70481e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2610564957","title":"艾切托盘中异动 早盘大幅下挫5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610564957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610564957?lang=zh_cn&edition=full","pubTime":"2026-02-12 00:05","pubTimestamp":1770825934,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日00时05分，艾切托股票出现波动，股价急速下跌5.19%。截至发稿，该股报6.76美元/股，成交量8.8398万股，换手率0.92%，振幅9.54%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。艾切托股票所在的生物技术行业中，整体跌幅为0.73%。艾切托公司简介：Adicet Bio Inc是一家临床阶段的生物技术公司，发现和开发用于癌症和其他疾病的异体γ δ T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021200053597a5d5a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021200053597a5d5a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2610937668","title":"艾切托盘中异动 股价大涨16.50%报8.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610937668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610937668?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:33","pubTimestamp":1770647588,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日22时33分，艾切托股票出现异动，股价急速上涨16.50%。截至发稿，该股报8.19美元/股，成交量3.445万股，换手率0.36%，振幅18.35%。艾切托股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，艾切托、Novabay Pharmaceuticals, Inc.、Anavex Life Sciences Corp.涨幅较大，Agomab Therapeutics Nv、Liminatus Pharma, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为57.29%、26.62%、19.80%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Genenta Science Spa、艾切托，振幅分别为34.95%、28.39%、18.35%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223308a48f9b40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223308a48f9b40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"1149318500","title":"艾切托生物公司：H.C. Wainwright将目标价调整至50美元，反映合股影响（澄清目标价已作合股调整）","url":"https://stock-news.laohu8.com/highlight/detail?id=1149318500","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149318500?lang=zh_cn&edition=full","pubTime":"2026-01-21 19:20","pubTimestamp":1768994427,"startTime":"0","endTime":"0","summary":"投资银行H.C. Wainwright宣布对艾切托生物公司的股票目标价进行调整。该机构将目标价从原先的9美元大幅上调至50美元，此次调整主要基于公司近期实施的合股操作。值得注意的是，此次更新的目标价已充分考虑合股因素，确保估值基准与实际股本结构保持一致。\n合股操作通常意味着公司对流通股数量进行缩减，而H.C. Wainwright此番调整旨在更精准地反映合股后每股对应的合理估值水平。这一变动凸显了机构对艾切托生物公司基本面及未来股价走势的重新评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2595646792","title":"艾切托盘中异动 股价大跌5.17%报0.493美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595646792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595646792?lang=zh_cn&edition=full","pubTime":"2025-12-29 23:00","pubTimestamp":1767020433,"startTime":"0","endTime":"0","summary":"北京时间2025年12月29日23时00分，艾切托股票出现波动，股价快速下跌5.17%。截至发稿，该股报0.493美元/股，成交量32.2782万股，换手率0.21%，振幅2.69%。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。艾切托股票所在的生物技术行业中，整体跌幅为0.29%。艾切托公司简介：Adicet Bio Inc是一家临床阶段的生物技术公司，发现和开发用于癌症和其他疾病的异体γ δ T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229230034a486939f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229230034a486939f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"1146490435","title":"艾切托董事会决定实施1:16反向拆股，以重新符合纳斯达克上市要求","url":"https://stock-news.laohu8.com/highlight/detail?id=1146490435","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146490435?lang=zh_cn&edition=full","pubTime":"2025-12-26 21:39","pubTimestamp":1766756388,"startTime":"0","endTime":"0","summary":"董事会决定实施1:16反向拆股。","market":"us","thumbnail":"https://static.tigerbbs.com/3a7cfe10c233dd9fd666e6ffca0b089f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3a7cfe10c233dd9fd666e6ffca0b089f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"36d2cbbd68707a64023a2bb80cee9e6d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACET"],"gpt_icon":0},{"id":"1124422264","title":"艾切托宣布首位患者在治疗难治性类风湿关节炎的Adi-001 1期临床试验中用药","url":"https://stock-news.laohu8.com/highlight/detail?id=1124422264","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124422264?lang=zh_cn&edition=full","pubTime":"2025-10-16 19:01","pubTimestamp":1760612481,"startTime":"0","endTime":"0","summary":"艾切托宣布首位患者在治疗难治性类风湿关节炎的Adi-001 1期临床试验中用药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2574119256","title":"艾切托盘中异动 早盘急速拉升5.45%报0.979美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574119256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574119256?lang=zh_cn&edition=full","pubTime":"2025-10-09 21:31","pubTimestamp":1760016671,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日21时31分，艾切托股票出现波动，股价急速上涨5.45%。截至发稿，该股报0.979美元/股，成交量7.1835万股，换手率0.09%，振幅2.37%。艾切托股票所在的生物技术行业中，整体跌幅为0.13%。艾切托公司简介：Adicet Bio Inc是一家临床阶段的生物技术公司，发现和开发用于癌症和其他疾病的异体γ δ T细胞疗法。消息层面，截至21时31分，《JonesTrading维持艾切托买入评级，上调目标价至5美元》资讯为影响艾切托的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213112a4585fa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213112a4585fa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"1140723589","title":"艾切托(Adicet Bio)公布Adi-001一期试验积极初步结果，针对狼疮性肾炎及系统性红斑狼疮患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1140723589","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140723589?lang=zh_cn&edition=full","pubTime":"2025-10-07 18:48","pubTimestamp":1759834108,"startTime":"0","endTime":"0","summary":"艾切托(Adicet Bio)公布Adi-001一期试验积极初步结果，针对狼疮性肾炎及系统性红斑狼疮患者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2567276908","title":"艾切托盘中异动 早盘大幅下跌11.34%报0.782美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567276908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567276908?lang=zh_cn&edition=full","pubTime":"2025-09-12 21:37","pubTimestamp":1757684246,"startTime":"0","endTime":"0","summary":"北京时间2025年09月12日21时37分，艾切托股票出现波动，股价急速跳水11.34%。截至发稿，该股报0.782美元/股，成交量2.9199万股，换手率0.04%，振幅5.12%。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。艾切托股票所在的生物技术行业中，整体跌幅为0.19%。艾切托公司简介：Adicet Bio Inc是一家临床阶段的生物技术公司，发现和开发用于癌症和其他疾病的异体γ δ T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509122137279528ddb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509122137279528ddb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2565692553","title":"艾切托盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565692553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565692553?lang=zh_cn&edition=full","pubTime":"2025-09-04 23:13","pubTimestamp":1756998830,"startTime":"0","endTime":"0","summary":"北京时间2025年09月04日23时13分，艾切托股票出现异动，股价大幅下跌5.21%。截至发稿，该股报0.692美元/股，成交量8.9609万股，换手率0.11%，振幅4.79%。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。艾切托股票所在的生物技术行业中，整体涨幅为0.17%。艾切托公司简介：Adicet Bio Inc是一家临床阶段的生物技术公司，发现和开发用于癌症和其他疾病的异体γ δ T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090423135195139a8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090423135195139a8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"1137865202","title":"艾切托生物根据纳斯达克上市规则5635(C)(4)报告诱导性股权授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1137865202","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137865202?lang=zh_cn&edition=full","pubTime":"2025-08-30 05:11","pubTimestamp":1756501902,"startTime":"0","endTime":"0","summary":"艾切托生物(Adicet Bio Inc)宣布，公司已根据纳斯达克上市规则5635(C)(4)的规定报告了诱导性股权授予情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2518266205","title":"艾切托盘中异动 股价大跌5.26%报0.754美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518266205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518266205?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:44","pubTimestamp":1741628642,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时44分，艾切托股票出现波动，股价大幅下跌5.26%。截至发稿，该股报0.754美元/股，成交量19.5048万股，换手率0.24%，振幅9.61%。机构评级方面，在所有7家参与评级的机构中，71%的券商给予买入建议，29%的券商给予持有建议，无券商给予卖出建议。艾切托股票所在的生物技术行业中，整体涨幅为0.85%。艾切托公司简介：Adicet Bio Inc是一家临床阶段的生物技术公司，发现和开发用于癌症和其他疾病的异体γ δ T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101440298a2cf18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101440298a2cf18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2518636281","title":"艾切托2024财年实现净利润-1.17亿美元，同比增加18.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518636281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518636281?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536076,"startTime":"0","endTime":"0","summary":"3月10日，艾切托公布财报，公告显示公司2024财年净利润为-1.17亿美元，同比增加18.18%；其中营业收入为0.00美元，每股基本收益为-1.33美元。从资产负债表来看，艾切托总负债33.61百万美元，其中短期债务3.13百万美元，资产负债比为0.07，流动比率为0.10。机构评级：截至2025年3月10日，当前有4家机构对艾切托目标价做出预测，其中目标均价为6.00美元，其中最低目标价为4.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000239a268987c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000239a268987c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACET"],"gpt_icon":0},{"id":"2517143791","title":"Adicet Bio(ACET.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.32美元，前值为-0.69美元，预期值为-0.35美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517143791","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517143791?lang=zh_cn&edition=full","pubTime":"2025-03-07 06:57","pubTimestamp":1741301843,"startTime":"0","endTime":"0","summary":"Adicet Bio(ACET.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.32美元，前值为-0.69美元，预期值为-0.35美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07065748578835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ACET"],"gpt_icon":0},{"id":"2517971381","title":"艾切托盘中异动 快速下跌5.03%报0.831美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517971381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517971381?lang=zh_cn&edition=full","pubTime":"2025-03-07 04:08","pubTimestamp":1741291680,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日04时08分，艾切托股票出现异动，股价快速跳水5.03%。截至发稿，该股报0.831美元/股，成交量40.1631万股，换手率0.49%，振幅5.73%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-30.48百万美元，每股收益-0.34美元，毛利-1.59百万美元，市盈率-0.49倍。艾切托股票所在的生物技术行业中，整体跌幅为1.17%。艾切托公司简介：Adicet Bio Inc是一家临床阶段的生物技术公司，发现和开发用于癌症和其他疾病的异体γ δ T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307040800963c86e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307040800963c86e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2516543766","title":"艾切托盘中异动 股价大跌5.07%报0.853美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516543766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516543766?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:17","pubTimestamp":1741025853,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时17分，艾切托股票出现波动，股价急速跳水5.07%。截至发稿，该股报0.853美元/股，成交量18.1711万股，换手率0.22%，振幅6.11%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-30.48百万美元，每股收益-0.34美元，毛利-1.59百万美元，市盈率-0.50倍。机构评级方面，在所有8家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。艾切托股票所在的生物技术行业中，整体涨幅为0.08%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021733989a434a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021733989a434a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2514344353","title":"艾切托盘中异动 大幅跳水5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514344353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514344353?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:54","pubTimestamp":1740686073,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时54分，艾切托股票出现波动，股价急速下跌5.49%。截至发稿，该股报0.853美元/股，成交量162.936万股，换手率1.98%，振幅8.43%。机构评级方面，在所有8家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。艾切托股票所在的生物技术行业中，整体跌幅为0.20%。艾切托公司简介：Adicet Bio Inc是一家临床阶段的生物技术公司，发现和开发用于癌症和其他疾病的异体γ δ T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228035434abdfb54b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228035434abdfb54b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2514019229","title":"艾切托盘中异动 早盘股价大跌5.91%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514019229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514019229?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:20","pubTimestamp":1740500400,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时20分，艾切托股票出现异动，股价急速下挫5.91%。截至发稿，该股报0.870美元/股，成交量17.6153万股，换手率0.21%，振幅4.77%。机构评级方面，在所有8家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。艾切托股票所在的生物技术行业中，整体涨幅为0.59%。艾切托公司简介：Adicet Bio Inc是一家临床阶段的生物技术公司，发现和开发用于癌症和其他疾病的异体γ δ T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600200096300a1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600200096300a1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2514705645","title":"艾切托盘中异动 临近收盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514705645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514705645?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:57","pubTimestamp":1740430651,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时57分，艾切托股票出现波动，股价快速跳水5.10%。截至发稿，该股报0.924美元/股，成交量64.1743万股，换手率0.78%，振幅8.69%。机构评级方面，在所有8家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。艾切托股票所在的生物技术行业中，整体跌幅为0.40%。艾切托公司简介：Adicet Bio Inc是一家临床阶段的生物技术公司，发现和开发用于癌症和其他疾病的异体γ δ T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225045731962ee37d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225045731962ee37d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACET"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.restorbio.com","stockEarnings":[{"period":"1week","weight":0.0455},{"period":"1month","weight":-0.128},{"period":"3month","weight":-0.2346},{"period":"6month","weight":-0.3936},{"period":"1year","weight":-0.5025},{"period":"ytd","weight":-0.1259}],"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0592},{"period":"1year","weight":0.1509},{"period":"ytd","weight":0.008}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"resTORbio, Inc.于2016年7月5日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，致力于新型治疗与治疗相关疾病的新疗法的开发与商业化。他们的领先项目已经在几项临床试验中得到证实，包括一项随机、安慰剂对照的试验，该试验有治疗多种衰老疾病的潜力，而这些疾病没有经过批准的治疗方法。在衰老或免疫衰老过程中，免疫功能的下降会增加对多种疾病的易感性，包括呼吸道感染，或RTIs，这对老年人的发病率和死亡率有很大的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.003466},{"month":2,"riseRate":0.555556,"avgChangeRate":0.004277},{"month":3,"riseRate":0.125,"avgChangeRate":-0.127363},{"month":4,"riseRate":0.5,"avgChangeRate":0.010766},{"month":5,"riseRate":0.375,"avgChangeRate":0.005307},{"month":6,"riseRate":0.25,"avgChangeRate":-0.066348},{"month":7,"riseRate":0.875,"avgChangeRate":0.156675},{"month":8,"riseRate":0.25,"avgChangeRate":-0.087324},{"month":9,"riseRate":0.375,"avgChangeRate":-0.03957},{"month":10,"riseRate":0.25,"avgChangeRate":-0.064136},{"month":11,"riseRate":0.5,"avgChangeRate":-0.065344},{"month":12,"riseRate":0.5,"avgChangeRate":0.055203}],"exchange":"NASDAQ","name":"艾切托","nameEN":"Adicet Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾切托(ACET)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾切托(ACET)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾切托,ACET,艾切托股票,艾切托股票老虎,艾切托股票老虎国际,艾切托行情,艾切托股票行情,艾切托股价,艾切托股市,艾切托股票价格,艾切托股票交易,艾切托股票购买,艾切托股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾切托(ACET)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾切托(ACET)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}